Search Results

Clearwater advises Harnham on its investment from BGF

Clearwater advises Achmea on the sale of Syntrus Achmea Pensioenbeheer to Centric

Karin Geiger

I joined Clearwater Switzerland as an Office Manager in 2023. In this role, I am the contact person and link between management, staff and customers and am responsible for the implementation of all administrative and organisational tasks within the company. My long professional career has been in the banking, finance and insurance sector: 15 years self-employed in personnel consulting for specialists and executives, Assistant to the board of directors and Office Manager for an international Art Insurance Company, Private Client Adviser in a Swiss Bank.

Clearwater outperforms in 2023 and expects improving conditions and growth in 2024

Clearwater advises on the recapitalisation of pharmaceutical services provider CHASE

Emmanuel Xerri

I founded the Clearwater team in Marseilles over 20 years ago. The Mediterranean region has many up-and-coming businesses which we are ideally placed to advise given our close proximity. I started my career in the corporate finance department of PwC and then joined EY. Following this I co-developed the activities of Edmond de Rothschild in Marseille for five years. Over the years, I have supported small and medium-sized companies that have sometimes become large corporations. The diversity of the transactions I have advised on makes me a generalist, or rather a multi-specialist across various sectors including business services, healthcare, industrials, specialised distribution, and TMT. More recently, I advised on the various build-up operations as well as the primary and secondary LBOs of the Cogepart Group, the French leader in last mile delivery. I also advised Hôpital Privée La Casamance on the merger with the Almaviva group and the entry of FrenchFood Capital into Markal, a major player in the organic food sector. Today, Clearwater International is ideally positioned to accompany clients through the increasingly rapid changes in the market, remaining adaptable and utilising our sector specialists in both our French and international teams to meet client goals.

Hemavli Bali

I joined Clearwater in December 2018 to lead M&A advisory within healthcare and life sciences technology and specialist services - including life science commercialisation services, e-clinical solutions, healthcare IT, software and IP driven consultancies. My 21 year career has traversed investment banks, Big Four firms and M&A boutiques and I joined Clearwater for its truly international team, passion for high quality client service, culture and dynamism. I have spent 16 years in M&A advisory, in the UK and the US, and advised on over 40 transactions across the sell- side, buy-side, owner-managed businesses, large corporates, private equity and public to private transactions. I have also provided extensive Board level advice both pre- and post-deal processes. The healthcare and life science industry, and its increasing technology enablement, has been my main focus throughout. Deals I have advised on include the sales of Age UK’s telecare business to Axa PPP Healthcare, Medaxial to Covance, Abacus International to Decision Resources Group and Synergy to DDB, Omnicom. I have previously held roles at Deloitte, Results International, Nomura, Royal Bank of Canada and Ernst & Young. I am a Chartered Accountant and hold a BSc in Economics from the London School of Economics.

Clearwater advises the shareholders of Guldberg and Personites on its sale to TMC

Adviser to the shareholders of Guldberg and Personites on its sale to TMC